#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transient ischaemic attack Mantle cell lymphoma Behcet's syndrome Pustular psoriasis Iron overload Non-small cell lung cancer Renal cancer metastatic Rectal cancer Mitochondrial DNA depletion Corneal neovascularisation Choroidal dystrophy Intracranial germ cell tumour Post transplant lymphoproliferative disorder Polyneuropathy Endometrial cancer More trials…

    Learn about Rare Diseases

    Vascular malformation – Treatment Prolymphocytic leukaemia – Treatment Idiopathic pulmonary fibrosis – Trials in Disease Myelodysplastic syndrome – Trials in Disease Inclusion body myositis – Basic Information Glycogen storage disease type II – Treatment Mantle cell lymphoma refractory – Life with Disease Leukoencephalopathy – Diagnostics Hereditary neuropathic amyloidosis – Trials in Disease Skin angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Hyaluronate Golexanolone Sodium Lactate Solution Adrenaline Acid Tartrate Bp Human Von Willebrand Factor TIFCEMALIMAB Pralatrexate Thiocolchicoside Sodium Cromoglicate Oxytocin Synthetic Tasimelteon Catequentinib Dihydrochloride Brexucabtagene Autoleucel Romidepsin Bempikibart Ads-011 68Ga-Nota-Abscint-Her2 Sym024 Erenumab Rifampicin More therapies…

    Learn about Your Condition

    Oesophageal atresia Dyspnoea Colorectal adenoma Joint stabilisation Ligament operation Hypoalbuminaemia Alcohol use disorder Infertility male Neurodermatitis Intestinal infarction Vulvovaginal candidiasis Interstitial lung disease Thrombocytosis Tooth loss Pneumonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • A Phase 4 Study of Crizanlizumab Treatment for Patients with Sickle Cell Disease Who Previously Participated in Novartis Clinical Trials

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Crizanlizumab
    Belgium France Germany Italy Spain

  • Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Axatilimab
    Belgium Czechia France Germany Italy Poland +2

  • Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Alxn2220
    Austria Belgium Czechia Denmark France Germany +8

  • Study Comparing Sepiapterin and Sapropterin for Treating Phenylketonuria in Patients Aged 2 Years and Older

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One
    • Sapropterin Dihydrochloride
    Czechia Denmark France Germany Italy The Netherlands +3

  • Study of Emrusolmin for Treating Adults with Multiple System Atrophy

    Not recruiting

    2 1
    Investigated Diseases:
    • Multiple system atrophy
    Investigated Drugs:
    • Emrusolmin
    France Germany Italy Spain

  • Study of long-term safety of octreotide subcutaneous depot (CAM2029) in patients with acromegaly

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • Octreotide Hydrochloride
    Germany Hungary Italy Poland Spain

  • Study on Long-Term Safety of Cendakimab for Adults and Adolescents with Eosinophilic Esophagitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Cendakimab
    Austria Belgium Germany Italy Poland Portugal +1

  • Study on Long-Term Safety of Donidalorsen for Patients with Hereditary Angioedema

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Donidalorsen
    Belgium Bulgaria France Germany Italy The Netherlands +2

  • Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Croatia Czechia Denmark Estonia +14

  • Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ozanimod
    Bulgaria Croatia Czechia France Germany Hungary +9
Previous Page
1 … 31 32 33 34 35 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!